Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_assertion wasGeneratedBy ECO_0000203 NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_assertion wasDerivedFrom befree-20150227 NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_assertion SIO_000772 15161671 NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_assertion evidence source_evidence_literature NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.
- NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_assertion description "[We now report that the levels of mRNAs encoding the cholesterol synthesis-regulating enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and the cholesterol-importing low-density lipoprotein (LDL) receptor were both increased by daunorubicin (DNR) or cytarabine (ARA-C) treatments in almost three fourths of cultured AML samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533417.RAXUdKulvUGP16KKX57Bl2O0Opf_eBTu640iAZWz-RjRg130_provenance.